First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Shares Up 0.3% – Time to Buy?

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) was up 0.3% during trading on Wednesday. The stock traded as high as $274.25 and last traded at $272.46. 58,524 shares traded hands during trading, a decline of 46% from the average session volume of 108,956 shares. The stock had previously closed at $271.77.

First Trust NYSE Arca Biotechnology Index Fund Stock Down 1.2%

The stock has a market cap of $2.96 billion, a P/E ratio of 21.72 and a beta of 0.66. The business’s 50-day simple moving average is $267.75 and its two-hundred day simple moving average is $242.21.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the business. Sequent Planning LLC boosted its holdings in shares of First Trust NYSE Arca Biotechnology Index Fund by 4.5% in the first quarter. Sequent Planning LLC now owns 1,150 shares of the company’s stock worth $231,000 after acquiring an additional 50 shares during the period. HF Advisory Group LLC grew its position in shares of First Trust NYSE Arca Biotechnology Index Fund by 5.0% in the second quarter. HF Advisory Group LLC now owns 1,270 shares of the company’s stock valued at $315,000 after purchasing an additional 60 shares in the last quarter. American Financial Advisors LLC raised its stake in shares of First Trust NYSE Arca Biotechnology Index Fund by 3.2% during the 1st quarter. American Financial Advisors LLC now owns 2,013 shares of the company’s stock valued at $404,000 after purchasing an additional 62 shares during the period. Capital Analysts LLC raised its stake in shares of First Trust NYSE Arca Biotechnology Index Fund by 39.3% during the 2nd quarter. Capital Analysts LLC now owns 227 shares of the company’s stock valued at $56,000 after purchasing an additional 64 shares during the period. Finally, Robertson Stephens Wealth Management LLC raised its stake in shares of First Trust NYSE Arca Biotechnology Index Fund by 2.5% during the 3rd quarter. Robertson Stephens Wealth Management LLC now owns 4,241 shares of the company’s stock valued at $1,155,000 after purchasing an additional 103 shares during the period.

First Trust NYSE Arca Biotechnology Index Fund Company Profile

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.